HEM Pharma Inc.
Microbiome biotech using analysis for personalized probiotics, LBPs, and full CDMO services.
376270 | KO
Overview
Corporate Details
- ISIN(s):
- KR7376270005
- LEI:
- Country:
- South Korea
- Address:
- 경기도 수원시 영통구 창룡대로256번길 50 711호, 수원시
- Website:
- https://hempharma.bio/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
HEM Pharma Inc. is a biotechnology company specializing in human microbiome research and technology. The company develops personalized healthcare solutions, probiotics, health functional foods, and Live Biotherapeutic Products (LBPs). Its core competency lies in its proprietary Personalized Microbiome Analysis System (PMAS), a screening platform used to identify and develop customized microbial solutions based on multi-omics and metabolome analysis. HEM Pharma also utilizes its MBR high-concentration fermentation technology for efficient production and offers Contract Development and Manufacturing Organization (CDMO) services through its GMP-certified facilities, supporting the entire lifecycle of microbiome-based products from research to manufacturing.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-26 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 1.5 MB | ||
| 2025-06-26 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | ||
| 2025-06-18 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | ||
| 2025-05-21 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.4 MB | ||
| 2025-05-08 00:00 |
Post-Annual General Meeting Information
임시주주총회결과
|
Korean | 4.9 KB | ||
| 2025-04-23 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 62.3 KB | ||
| 2025-04-03 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 6.8 KB | ||
| 2025-03-31 00:00 |
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 11.5 KB | ||
| 2025-03-31 00:00 |
Share Issue/Capital Change
주식매수선택권부여에관한신고
|
Korean | 16.2 KB | ||
| 2025-03-31 00:00 |
Regulatory News Service
본점소재지변경
|
Korean | 5.3 KB | ||
| 2025-03-31 00:00 |
Pre-Annual General Meeting Information
주주총회소집결의
|
Korean | 6.2 KB | ||
| 2025-03-31 00:00 |
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
|
Korean | 4.1 KB | ||
| 2025-03-31 00:00 |
Post-Annual General Meeting Information
정기주주총회결과
|
Korean | 31.0 KB | ||
| 2025-03-31 00:00 |
Regulatory News Service
[기재정정]신규시설투자등
|
Korean | 12.1 KB | ||
| 2025-03-21 00:00 |
Audit Report / Information
감사보고서제출
|
Korean | 19.1 KB |
Automate Your Workflow. Get a real-time feed of all HEM Pharma Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for HEM Pharma Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for HEM Pharma Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
